WAHTN Website

Tag: 2019

  • 2019 Australian British Health Catalyst Delegation

    Australia and the UK face similar challenges: ageing populations, increased healthcare costs and pressures on Government and Health Insurance funding. The Australian British Health Catalyst 2019 theme is Integrated Healthcare in a Digital World.

     

    Aimed at healthcare leaders the Delegations’ main goal is to facilitate greater two-way trade and investment between the United Kingdom and Australia by bringing senior corporate and government representatives together. There is also the aim of developing and delivering a return on knowledge through collaboration and exchange of innovative initiatives

     

    Following the success of the Infrastructure and Financial Services delegations, the Health Catalyst representatives will travel to London and Cambridge in early July 2019. The programme will examine patient-centric digital health technologies – from better management of records, facilities and diagnoses, what the care network of the future looks like, and how to recognise the cyber security challenges of today

     

    Event Details:

    Date: 8 – 11 July

    Time: All day events, see Programme Flyer for more details

    Location: London & Cambridge, UK

    For more information download the Australian British Health Catalyst 2019 Programme Flyer, or contact Andrew Turnbull or David McCredie

  • Federal Budget win for WAHTN

    The Federal Government has announced it will continue to support medical and health research by investing a significant amount of funds into the national Alliance of Advanced Health Research Translation Centres, which includes WAHTN. The Australian Health Research Alliance has been awarded $218 million in funding for Rapid Applied Research Translation over the next ten years.

     

    This funding and long-term investment represents a major endorsement of the Translational Research Centres and our leading role in accelerating the translation of research into policy and practice for greater health impact. The funding will support collaboration and our efforts toward enhancing integration across healthcare, research and education.

     

    Executive Director of WAHTN, Professor Gary Geelhoed has said “We’re extremely happy that the federal budget included continued funding of the national Advanced Health Research Translation Centres. It shows an ongoing commitment by the federal government to these Centres and recognises their increasing importance to healthcare in Australia. It will allow WAHTN to continue our leading role in promoting, supporting and translating medical research into better healthcare for all West Australians”

     

    Working together through partnership, commitment and engagement we can continue our journey delivering better healthcare through research.

     

    Find out more info

  • 2019 NHMRC Symposium on Research Translation calling for Abstracts

    The 8th Annual NHMRC Symposium on Research Translation will be held in Melbourne on 19 – 20 November, 2019.

     

    The theme for this year is Research Translation in the digital age: harnessing the power of data and analytical technologies.

     

    The call for Abstracts to be submitted is now open. Successful authors will be offered either an oral or poster presentation. All Abstracts must be submitted by Monday 1 July, 2019. 

     

    For enquires on submission please contact NHMRC

    Click here to submit an Abstract to NHMRC

  • 2019 REDCap Workshops

    The Telethon Kids Institute’s Biometrics team provides access to REDCap for all Telethon Kids, Child and Adolescent Health Service (CAHS), and Perth Children’s Hospital (PCH) researchers.

    The workshops are intended as a hands on approach for researchers wanting to learn how to build and manage projects within REDCap or further develop skills in order to make use of some of REDCap’s more advanced features.

     

    The REDCap Basics workshop will offer an introduction to building databases in REDCap and will cover basic concepts and best practices to equip researchers in building a database for their research project. This workshop will be most useful to anyone building a new project in REDCap and those who have been tasked with managing or maintaining an existing database.

     

    The REDCap Intermediate workshops offers a more comprehensive look at creating a database and using surveys, and will build upon the topics introduced in the REDCap Basics workshop. Those attending this workshop should be familiar with navigating and using REDCap for project set-up and will be most beneficial to those who have identified an upcoming need for the advanced functionality covered in this workshop.

     

    For more info contact the Research Education Program

     

    Session Dates:

    Basics – Monday, 6 May 2019 – Book here

    Intermediate – Wednesday, 5 June 2019 – Book here

    Advanced* – Wednesday, 3 July 2019 – TBA

    *To attend the Advanced workshop you must have either previously attended one of the preliminary sessions (Basics or Intermediate) OR be able to demonstrate you are already administering projects within REDCap

  • Multiple Genomics Health Grant Opportunities

    The Federal Health Department has launched three Genomics Health Grant Opportunities. The $156 million Projects Grant stream and the $17.6 million Ethical, Legal and Social Issues Research Grant stream. There’s also the $106 million Flagships stream. All of which form part of the Genomics Health Futures Mission (GHFM) and will be delivered over nine years from 2019-20 to 2027-28 through a number of rounds.

     

    To be eligible you must:

    • Have an Australian Business Number (ABN)
    • Be incorporated in Australia
    • As per s24 of the Medical Research Future Fund Act 2015 you must be one of the following eligible bodies:
      • a medical research institute
      • a university
      • a corporate Commonwealth entity
      • a corporation (including businesses and not for profits)

    Joint applications are encouraged, provided you have a lead applicant who’s the main driver of the project and is eligible to apply.

     

    Read more about the Genomics Health Futures Mission – Projects & Ethics Grant Opportunities Applications close 3pm, Friday 31 May

    Read more about the Genomics Health Futures Mission – Flagships – Pathogen Genomics Opportunity Applications close 3pm, Thursday 11 July

  • Are you WA’s next Innovator of the Year?

    Applications are now open for the WA Innovator of the Year (IOTY).  The IOTY Awards showcase innovative and entrepreneurial individuals, businesses, and creative minds in a variety of fields. Health and medical projects have been selected as finalists in years previous – take a look at the 2018 finalists.

     

    Past winners include UWAs The Noisy Guts Project

     

    And the Chemo@Home project

    There are 16 semi-finalists to be awarded and they’ll receive intensive business commercialisation training including:

    • Pitch presentation training
    • One-on-one mentoring
    • Legal health check
    • Financial planning tools

     

    Eight finalists will also additionally receive a professionally edited video of their innovation.

     

    An Applicant information session will be held on Monday 1 April, at ECU Joondalup. To reserve a space please email Penny Harker

     

    Read the application guidelines

    Click here for more information

  • Don’t miss out on the 2019 Activity Based Funding Conference!

    The Independent Hospital Pricing Authority (IHPA) will hold its Activity Based Funding Conference 2019 (ABF19) at the Melbourne Convention and Exhibition Centre from Monday 13 to Wednesday 15 May, 2019.

     

    Following on from the success of previous years, IHPA is excited to host industry leaders, policymakers and front-line health care professionals from Australia, and around the world for the 6th iteration of the conference series.

     

    With 400 leading professionals expected to attend, the conference theme Activity Based Funding: Cost, Value and Outcomes will be the centre of lively discussion over the course of the 3-day program – including insightful workshops, keynote addresses, plenary and panel sessions.

     

    Delegates will also have the opportunity to connect with like-minded counterparts while experiencing the best hospitality Melbourne has to offer through a networking function and gala dinner.

     

    Event Details:

    Date: 13 – 15 May, 2019

    Location: Melbourne Convention and Exhibition Centre

    More Info

  • Science on the Swan Abstract Submission Date

    2019 Science on the Swan gives you the opportunity to share your research with world-leading health and science professionals.

     

    The 2019 Conference theme is Neuroscience and the Senses: Healthy Ageing across the Life Course. Don’t miss your chance to submit your abstract to be part of the Conference Program.

     

    Applications close Friday 15 March, 2019

    View the Abstract Submission Guidelines

  • 2019 CCRM Australia – WAHTN Technology Evaluation Workshop

    WAHTN in partnership with the Centre for Cell Therapy and Regenerative medicine (CCTRM) and the Centre for Commercialisation of Regenerative Medicine (CCRM) Australia are happy to announce the 2019 CCRM Australia – WAHTN Technology Evaluation Workshop.

     

    The Workshop coincides with the visit of the Canadian CEO of CCRM, Dr Michael May, who will be visiting Perth in May this year. Dr May will be in attendance at the Workshop and will be able to provide feedback on participant presentations. In previous Technology Evaluation Workshops participants have received valuable feedback from Dr May, and in some cases, participants have been referred to other contacts in the same research area.

     

    CCRM is a leading Canadian not-for-profit which develops new cutting edge technologies in the field of regenerative medicine, including cell and gene therapy.

     

    While CCRM are open to new technologies which advance the field of regenerative medicine, the following are also of interest:

     

    Cell and gene therapy:

    • T cell immunotherapies (CAR-T), target discovery platforms, and biomarkers to identify potent T cell subsets
    • Generation of universal antigen specific T-cells
    • Genetic modifications for enhanced cell targeting
    • Exosomes-based delivery of therapeutics
    • Cardiac/neural cell therapies
    • Small molecules for endogenous repair
      • Small molecule and mimetic alternatives to protein factors (e.g. growth factors) to be used for manufacturing
      • Novel defined (recombinant proteins only) medium formulations for production of commercially relevant cell types
    • Gene therapy approaches

     

    Enabling Technologies:

    • Human PSC differentiation
    • Label-free cell isolation
    • Gene/epigenome editing and non-viral delivery
      • Cell engineering (genetic switches, rapid clone selection, hot-swappable regions, integration site targeting, expression stability, etc)
    • Lentiviral transfection and transduction
      • High-efficiency cell transduction (e.g. process related or new LVV envelope proteins)
    • AAV for targeted delivery including novel AAV capsids

     

    Manufacturing:

    • Non-enzymatic passaging of cells in bioreactors
    • New bioreactor technologies relevant to manufacture of commercially relevant cell types
      • High efficiency volume reduction and washing, should be scalable (e.g. from 1L scaled to a magnitude of 100 or more)
    • Virus filtration/clarification/isolation methods (LVV and AAV)
      • High efficiency and high purity continuous enrichment of virions (lentivirus and AAV) from cell culture broth
    • Rapid assays for quantification of functional viral titre (lentivirus and AAV) new approaches to support manufacturing workflow i.e.:
      • Tracking technologies (materials, equipment, products and people)
      • Process data capture/monitoring and interrogation
      • Procedural tracking
      • Process modelling and scheduling
    • Media development and formulations
      • New algorithms/methods for efficient exploration of high dimensional design spaces in media development and culture optimisation
      • Low cost, high efficiency, scalable cell enrichment
    • Sensors to measure cell viability and biomass:
      • In-reactor analysis of media composition (metabolites, proteins, physico-chemical parameters)
      • In-reactor or rapid at-line and automated analysis of cell phenotype
        • In both cases preferably g-irradiation stable and single use
    • Rapid assays for detection of microbiological contamination

     

    Event Details:

    Date: Thursday 23 May 2019

    Time: 14:30 – 16:30

    Location: McCusker Auditorium, the Harry Perkins Institute of Medical Research (North)

    Bookings are essential and will fill up fast. Place yours now

  • Deadline Closing for Allied Health Clinician Research Fellowships

    The Clinician Research Fellowships are an initiative of the WA Department of Health in partnership with the Raine Medical Research Foundation.

    The program is designed to encourage clinicians employed by Health Service Providers to develop their research capability, while continuing some clinical duties. The program also facilitates high quality research which will ultimately provide better healthcare outcomes. The research must be undertaken in WA and be of direct relevance to the WA health system.

    The program is open to eligible clinicians:

    • Working in healthcare disciplines including allied health and health sciences, dental, medical, nursing and midwifery professions
    • Who are either early or mid-career researchers
    • Who have minimal or no paid research time

    Fellowship funding will provide salary support for research duties up to 0.5 FTE, as well as contribute to minor research costs. The duration of each Fellowship can be up to three years, depending on the extent of the research proposal. during the term of the Fellowship, clinical duties in a Health Service Provider must be maintained at a minimum of 0.3 FTE.

     

    Applications close 1pm 28 March, 2019.

    View the Guidelines and Conditions and the Application documents

Powered by
►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
Powered by